Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
Open Access
- 26 April 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11
Abstract
The acquisition of resistance to anoikis, the cell death induced by loss of adhesion to the extracellular matrix, is an absolute requirement for the survival of disseminating and circulating tumour cells (CTCs), and for the seeding of metastatic lesions. In melanoma, a range of intracellular signalling cascades have been identified as potential drivers of anoikis resistance, however a full understanding of the process is yet to be attained. Mechanisms of anoikis resistance pose an attractive target for the therapeutic treatment of disseminating and circulating melanoma cells. This review explores the range of small molecule, peptide and antibody inhibitors targeting molecules involved in anoikis resistance in melanoma, and may be repurposed to prevent metastatic melanoma prior to its initiation, potentially improving the prognosis for patients.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 369 references indexed in Scilit:
- ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosisCell Death & Disease, 2013
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanomaBritish Journal of Cancer, 2011
- c-Jun Promotes whereas JunB Inhibits Epidermal NeoplasiaJournal of Investigative Dermatology, 2011
- Circulating Tumor Cells as a Window on Metastasis Biology in Lung CancerThe American Journal of Pathology, 2011
- ErbB/EGF Signaling and EMT in Mammary Development and Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2010
- Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell linesUrologic Oncology: Seminars and Original Investigations, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- IntegrinsCell and tissue research, 2009
- Rac Activation and Inactivation Control Plasticity of Tumor Cell MovementCell, 2008
- IntegrinsCell, 2002